Probuphine for Opioid Addiction
Tuesday, 16 August 2016
by Max Menius

Probuphine is a new drug recently developed and released by Braeburn Pharmaceuticals. The drug is FDA-approved and is a time-released version of buprenorphine (the active ingredient in Suboxone that staves off opioid withdrawal symtoms). Probuphine must be implanted beneath the patient’s skin (typically in the arm) where it gradually distributes medication for 6 months. The


Subscribe to ADS Posts

ADS Articles
Got Meds Disposal Drive 4-22-2022
ADS and its community partners are sponsoring a...Got Meds Disposal Drive 4-9-2022
ADS and its community partners are sponsoring a...February Is American Heart Month
Guarding your heart health is an important life...Tips For Getting and Staying Healthy in 2022
The new year is here! Here are some tips for ge...Lethal Fentanyl Is On The Rise
The Centers for Disease Control and Prevention ...Job Opening: Director of Prevention and Early Intervention Services
Seeking qualified candidate for Director of Pre...
